Antimicrobial resistance of Streptococcus pneumoniae in Southeast Austria, 1997-2008.

[1]  P. Apfalter,et al.  Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria , 2009, BMC infectious diseases.

[2]  D. Greenberg,et al.  The Association Between Antibiotic Use in the Community and Nasopharyngeal Carriage of Antibiotic-Resistant Streptococcus pneumoniae in Bedouin Children , 2008, The Pediatric infectious disease journal.

[3]  S. Richter,et al.  Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  J. Shin,et al.  Prevalence, Characteristics, and Molecular Epidemiology of Macrolide and Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae at Five Tertiary-Care Hospitals in Korea , 2007, Antimicrobial Agents and Chemotherapy.

[5]  C. Hoban,et al.  Molecular Characterization of Increasing Fluoroquinolone Resistance in Streptococcus pneumoniae Isolates in Canada, 1997 to 2005 , 2006, Antimicrobial Agents and Chemotherapy.

[6]  F. J. Méndez,et al.  Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain. , 2006, Japanese journal of infectious diseases.

[7]  E. McIntosh,et al.  Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient? , 2006, International journal of clinical practice.

[8]  A. Sandgren,et al.  Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  D. Low.  Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. P. van der Linden,et al.  Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003 , 2005, Antimicrobial Agents and Chemotherapy.

[11]  A. Steigerwalt,et al.  Accuracy of Phenotypic and Genotypic Testing for Identification of Streptococcus pneumoniae and Description of Streptococcus pseudopneumoniae sp. nov , 2004, Journal of Clinical Microbiology.

[12]  W. Graninger,et al.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria. , 2004, The Journal of antimicrobial chemotherapy.

[13]  S. Gillespie,et al.  Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. , 2004, International journal of antimicrobial agents.

[14]  I. Morrissey,et al.  Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. , 2003, The Journal of antimicrobial chemotherapy.

[15]  P. Huovinen,et al.  Antimicrobial Resistance of Invasive Pneumococci in Finland in 1999-2000 , 2003, Antimicrobial Agents and Chemotherapy.

[16]  P. Appelbaum.  Resistance among Streptococcus pneumoniae: Implications for drug selection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  P. Rhomberg,et al.  Antimicrobial Resistance among Clinical Isolates ofStreptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995 , 2001, Antimicrobial Agents and Chemotherapy.

[18]  C. Seral,et al.  Distribution of resistance genes tet(M), aph3'-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. , 2001, The Journal of antimicrobial chemotherapy.

[19]  J. Ambler,et al.  Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland. , 1998, The Journal of antimicrobial chemotherapy.

[20]  M. Miller,et al.  Optochin Revisited: Defining the Optimal Type of Blood Agar for Presumptive Identification of Streptococcus pneumoniae , 1998, Journal of Clinical Microbiology.

[21]  M. Haditsch,et al.  Antibiotic susceptibility of pneumococci isolated in Austria over a four-year period , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  D. Musher.  Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  L. Lambertsen,et al.  Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates. , 2010, International journal of antimicrobial agents.

[24]  H. Mittermayer,et al.  The European surveillance activities EARSS and ESAC in the context of ABS International , 2008, Wiener klinische Wochenschrift.

[25]  F. Baquero,et al.  Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  A. Marchese,et al.  Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy. , 2000, Microbial drug resistance.

[27]  Steven D. Brown,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Trends in Antibacterial Resistance among Streptococcus Pneumoniae Isolated in the Usa: Update from Protekt Us Years 1–4 , 2022 .